持续气道正压通气对冠心病合并阻塞性睡眠呼吸暂停但无过度嗜睡患者的心血管获益
结果显示,CPAP相关风险降低随治疗前ΔHR升高而递增(交互HR 0.49,95%CI 0.27-0.90,P<0.05);ΔHR高于均值1个SD(10次/分)者估计风险降低59%,而均值ΔHR(6次/分)者无显著降低。
要点
- CPAP对冠心病合并OSA无心过度嗜睡患者的心血管保护作用受基线ΔHR修饰。
- ΔHR每增加1个SD,CPAP相关心血管风险降低的交互HR为0.49(95%CI 0.27-0.90)。
- ΔHR 10次/分者CPAP估计降低心血管风险59%(6%-82%),6次/分者无显著降低。
核心结论
- 在冠心病合并OSA且无过度嗜睡的患者中,CPAP的心血管保护作用被治疗前ΔHR修饰,ΔHR较高者获得更大心血管获益。
研究设计与样本
- RICCADSA随机对照试验的事后分析,纳入冠心病合并OSA(AHI≥15次/小时)且Epworth嗜睡量表评分<10的患者,nCPAP组113例、对照组113例;男性85%,年龄66±8岁。
主要发现
- CPAP相关风险降低随治疗前ΔHR升高而递增,交互HR(95%CI)为0.49(0.27-0.90)/ΔHR每增加1个SD,P<0.05。
- ΔHR高于均值1个SD(10次/分)者,CPAP估计降低心血管风险59%(6%-82%),P<0.05。
- ΔHR为均值(6次/分)者,CPAP估计风险降低16%(-53%-54%),P=0.6,无显著降低。
关键数值与推荐
- 主要结局为重复血运重建、心肌梗死、卒中和心血管死亡的复合终点。
- ΔHR每增加1个SD的交互HR为0.49(95%CI 0.27-0.90),P<0.05。
- ΔHR 10次/分者CPAP风险降低59%(95%CI 6%-82%),P<0.05;ΔHR 6次/分者风险降低16%(95%CI -53%-54%),P=0.6。
临床怎么用
- 对冠心病合并OSA且无过度嗜睡的患者,可参考基线ΔHR评估CPAP的心血管获益可能性。
- ΔHR较高者可能从CPAP治疗中获得更明确的心血管风险降低。
局限性
- 本研究为随机对照试验的事后分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Randomized controlled trials of continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA) have not demonstrated protection against adverse cardiovascular outcomes. Recently, observational studies revealed that OSA-related cardiovascular risk is concentrated in patients with an elevated pulse rate response to respiratory events (ΔHR). Objectives: Here, in this post hoc analysis of a prospective clinical trial, we test the hypothesis that a greater pretreatment ΔHR is associated with greater CPAP-related protection against adverse cardiovascular outcomes. Methods: ΔHR was measured from baseline polysomnography of the RICCADSA (Randomized Intervention with CPAP in CAD and OSA) randomized controlled trial (patients with coronary artery disease [CAD] and OSA [apnea-hypopnea index ⩾ 15 events/h] with Epworth Sleepiness Scale score < 10; nCPAP:ncontrol = 113:113; male, 85%; age, 66 ± 8 [mean ± SD] yr). The primary outcome was a composite of repeat revascularization, myocardial infarction, stroke, and cardiovascular mortality. Multivariable Cox regression assessed whether the effect of CPAP was moderated by ΔHR (treatment-by-ΔHR interaction). Measurements and Main Results: The CPAP-related reduction in risk increased progressively with increasing pretreatment ΔHR (interaction hazard ratio [95% confidence interval], 0.49 [0.27 to 0.90] per SD increase in ΔHR; P < 0.05). This means that in patients with a ΔHR of 1 SD above the mean (i.e., 10 beats/min), CPAP was estimated to reduce cardiovascular risk by 59% (6% to 82%) (P < 0.05), but no significant risk reduction was estimated in patients with a mean ΔHR (6 beats/min; CPAP risk reduction, 16% [-53% to 54%]; P = 0.6). Conclusions: The protective effect of CPAP in patients with CAD and OSA without excessive sleepiness was modified by the ΔHR. Specifically, patients with higher ΔHR exhibit greater cardiovascular benefit from CPAP therapy.
引用
- Azarbarzin A, Zinchuk A, Wellman A, et al. Cardiovascular Benefit of Continuous Positive Airway Pressure in Adults with Coronary Artery Disease and Obstructive Sleep Apnea without Excessive Sleepiness. Am J Respir Crit Care Med. 2022. PMID: 35579605. doi:10.1164/rccm.202111-2608OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。